Firefly Neuroscience, Inc.
AIFF
$3.20
-$0.01-0.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 108.00K | 74.00K | 64.00K | 505.00K | 498.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 108.00K | 74.00K | 64.00K | 505.00K | 498.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 108.00K | 74.00K | 64.00K | 505.00K | 498.00K |
| SG&A Expenses | 7.33M | 6.71M | 3.57M | 3.22M | 2.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.29M | 8.26M | 4.63M | 4.13M | 3.58M |
| Operating Income | -9.18M | -8.19M | -4.56M | -3.62M | -3.08M |
| Income Before Tax | -10.46M | -7.75M | -4.11M | -3.17M | -2.60M |
| Income Tax Expenses | 2.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Earnings from Continuing Operations | -10.46 | -7.75 | -4.11 | -3.17 | -2.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.46M | -7.75M | -4.11M | -3.17M | -2.60M |
| EBIT | -9.18M | -8.19M | -4.56M | -3.62M | -3.08M |
| EBITDA | -8.08M | -7.08M | -3.46M | -2.52M | -3.06M |
| EPS Basic | -1.09 | -0.95 | -0.52 | -0.50 | -0.51 |
| Normalized Basic EPS | -0.62 | -0.59 | -0.32 | -0.31 | -0.32 |
| EPS Diluted | -1.09 | -0.95 | -0.52 | -0.50 | -0.51 |
| Normalized Diluted EPS | -0.62 | -0.59 | -0.32 | -0.31 | -0.32 |
| Average Basic Shares Outstanding | 115.68M | 110.66M | 107.26M | 92.59M | 60.74M |
| Average Diluted Shares Outstanding | 115.68M | 110.66M | 107.26M | 92.59M | 60.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |